Literature DB >> 17890824

Toxoplasma seroprevalence in healthy voluntary blood donors from urban Karnataka.

P Sundar1, A Mahadevan, R S Jayshree, D K Subbakrishna, S K Shankar.   

Abstract

BACKGROUND &
OBJECTIVES: Although many infections can be transmitted through blood transfusion, it is not possible to carry out screening tests for all. Among the protozoal diseases transmitted by blood transfusion in India the most important is malaria, followed by toxoplasmosis. Screening for malaria is mandatory in India. We evaluated the seroprevalence of Toxoplasma gondii in healthy adult population of blood donors in Karnataka, south India.
METHODS: A total of 1000 serum samples collected in two batches (500 each) in the years 2004 and 2005 from healthy voluntary blood donors were tested for T. gondii antibodies by ELISA method, in addition to the other five mandatory tests.
RESULTS: Overall 20.3 per cent were positive for T. gondii IgG antibody, of which, 63 per cent had high and 7 per cent low avidity, 3.6 per cent IgM positive. IgG titre ranged from 18-362 IU/ml. INTERPRETATION &
CONCLUSION: Our study showed a high prevalence of T. gondii antibodies in healthy voluntary blood population. It may be appropriate to include screening for T. gondii also in the pretransfusion blood testing schedule.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890824

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  20 in total

1.  Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt.

Authors:  Hany M Elsheikha; Manar S Azab; Nashwa K Abousamra; Mohammad H Rahbar; Doaa M Elghannam; Douaa Raafat
Journal:  Parasitol Res       Date:  2009-02-06       Impact factor: 2.289

2.  Seroprevalence of Toxoplasma gondii in southern districts of Tamil Nadu using IgG-ELISA.

Authors:  G Sucilathangam; N Palaniappan; C Sreekumar; T Anna
Journal:  J Parasit Dis       Date:  2012-03-13

3.  Seroepidemiological study of toxoplasmosis in southern districts of Tamil Nadu.

Authors:  G Sucilathangam; T Anna
Journal:  J Parasit Dis       Date:  2014-08-24

4.  Psychiatric aspects of toxoplasmosis: an Indian perspective.

Authors:  Ajish G Mangot
Journal:  J Parasit Dis       Date:  2015-05-15

5.  Pantothenic acid biosynthesis in the parasite Toxoplasma gondii: a target for chemotherapy.

Authors:  Sarmad N Mageed; Fraser Cunningham; Alvin Wei Hung; Hernani Leonardo Silvestre; Shijun Wen; Tom L Blundell; Chris Abell; Glenn A McConkey
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

6.  Neuropathological correlate of the "concentric target sign" in MRI of HIV-associated cerebral toxoplasmosis.

Authors:  Anita Mahadevan; Arvinda Hanumantapura Ramalingaiah; Satishchandra Parthasarathy; Avindra Nath; Udaykumar Ranga; Shankar Susarla Krishna
Journal:  J Magn Reson Imaging       Date:  2013-02-25       Impact factor: 4.813

7.  Seroprevalence of toxoplasmosis in voluntary blood donors of Puducherry and surrounding districts of Tamil Nadu.

Authors:  Selvaraj Stephen; Jothimani Pradeep; Velmurugan Anitharaj; Venkatraman Janarthanam
Journal:  J Parasit Dis       Date:  2017-07-25

8.  Utility of molecular and serodiagnostic tools in cerebral toxoplasmosis with and without tuberculous meningitis in AIDS patients: A study from South India.

Authors:  Sreenivas Adurthi; Anita Mahadevan; Radhika Bantwal; Parthasarthy Satishchandra; Sujay Ramprasad; Hema Sridhar; S K Shankar; Avindra Nath; R S Jayshree
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

9.  Diagnosis of cerebral toxoplasmosis.

Authors:  Sreenivas Adurthi; Anita Mahadevan; Radhika Bantwal; Parthasarthy Satishchandra; Sujay Ramprasad; Hema Sridhar; S K Shankar; Avindra Nath; R S Jayshree
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

10.  Evaluation of confounders in toxoplasmosis indirect fluorescent antibody assay.

Authors:  M Saraei; S Shojaee; Ar Esmaeli; H Jahani-Hashemi; H Keshavarz
Journal:  Iran J Parasitol       Date:  2010-12       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.